Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C).

Rachel WongMargaret A HallTalia WiggenSteven G JohnsonJared D HulingLindsey E TurnerKenneth J WilkinsHsin-Chieh YehTil StürmerCarolyn T BramanteJohn B BuseJane Reuschnull null

Published in: Diabetes care (2024)

Incident diabetes risk after COVID-19 was similar across different SARS-CoV-2 variants. However, there was greater latency in diabetes onset in the Omicron variant era.

Keyphrases

sars cov
cardiovascular disease
respiratory syndrome coronavirus
type diabetes
coronavirus disease
glycemic control
quality improvement
gene expression
adipose tissue
copy number
metabolic syndrome
insulin resistance
genome wide